Eptifibatide non cyclic impurity
|
|
Eptifibatide non cyclic impurity Eigenschaften
- Dichte
- 1.55±0.1 g/cm3(Predicted)
- pka
- 4.20±0.10(Predicted)
Sicherheit
Eptifibatide non cyclic impurity Chemische Eigenschaften,Einsatz,Produktion Methoden
Eptifibatide non cyclic impurity Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Eptifibatide non cyclic impurity Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 7)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
China National Standard Pharmaceutical Corporation Limited | +8615391658522 |
overseasales@yongstandards.com | China | 11922 | 58 |
Hubei Yangxin Medical Technology Co., Ltd. | 15374522761 |
3003392093@qq.com | China | 8705 | 55 |
Nanjing Huanuo Biomedical Technology Co., Ltd | 18913906212 |
2885426135@qq.com | China | 7160 | 58 |
Shenzhen Excellent Biomedical Technology Co., Ltd. | 18318671572 |
2850803126@qq.com | China | 4897 | 58 |
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd | 18162595016; 18162595016 |
3287908757@qq.com | China | 9122 | 58 |
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd | 18102736234 18102736234 |
2208093734@qq.com | China | 7664 | 58 |
135900-78-6()Verwandte Suche:
- Eptifibatide non cyclic impurity
- L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-
- Eptifibatide Impurity 10
- 135900-78-6